Search results for "cancer diagnosis"

Novel contrast agent is being developed to address the medical need of patients with poor kidney function

The first patients have been enrolled in this trial to help treatment for Amyotrophic Lateral Sclerosis (ALS)

Avacta and Liverpool School of Tropical Medicine collaborate to clinically validate saliva-based rapid coronavirus test being developed with Cytiva

Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution

Antibiotic; mTOR pathway inhibitor; Inhibits FKBP-12

Epigenetic modifier; Inhibitor of Sir2p, SIRT1, and SIRT2

Tyrosine kinase inhibitor; Inhibits VEGFR1, KDR, FLT-4, EGFR, FGFR, ABL, RET, and SRC

WNT pathway inhibitor; Inhibits TNKS1 and TNKS2

Epigenetic modifier; Inhibits DNA methyltransferase (DNMT)

PI3K/AKT pathway inhibitor; Inhibits AKT

mTOR, PI3K/AKT, NF-kB, and tyrosine kinase pathway inhibitor; Inhibits PI3K and SRC kinases

Point-of-care technology allows clinicians to access vital results when they need them most

Based on ESCAPE™ RNA sequencing technology, the latest proteogenomics assay is designed to characterize both RNA and protein expression levels across thousands of single CAR T cells

Commercially available xMAP® MultiFLEX™ Zika RNA assay, designed by GenArraytion, Inc., detects 6 genetic targets of Zika virus